Pedersen M, Madsen P, Klokker M, Olesen H L, Secher N H
Department of Anaesthesia, University of Copenhagen, Denmark.
Acta Physiol Scand. 1995 Dec;155(4):435-44. doi: 10.1111/j.1748-1716.1995.tb09993.x.
Sympathetic beta-adrenergic influences on cardiovascular responses to 50 degrees head-up tilt were evaluated with metoprolol (beta 1-blockade; 0.29 mg kg-1) and propranolol (beta 1 and beta 2-blockade; 0.28 mg kg-1) in eight males. A normotensive-tachycardic phase was followed by a hypotensive-bradycardic episode associated with presyncopal symptoms after 23 +/- 3 min (control, mean +/- SE). Head-up tilt made thoracic electrical impedance (3.0 +/- 1.0 omega), mean arterial pressure (MAP, 86 +/- 4-93 +/- 4 mmHg), heart rate (HR, 63 +/- 3-99 +/- 10 beats min-1) and total peripheral resistance (TPR, 15 +/- 1-28 +/- 4 mmHg min L-1) increase, while central venous oxygen saturation (74 +/- 2-58 +/- 4%), cardiac output (5.7 +/- 0.1-3.1 +/- 0.3 L min-1), stroke volume (95 +/- 6-41 +/- 5 mL) and pulse pressure (55 +/- 4-49 +/- 4 mmHg) decreased (P < 0.05). Central venous pressure decreased during head-up tilt (7 +/- 2-0 +/- 1 mmHg), but it remained stable during the sustained tilt. At the appearance of presyncopal symptoms MAP (49 +/- 3 mmHg), HR (66 +/- 4 beats min-1) and TPR (15 +/- 3 mmHg min L-1) decreased (P < 0.05). Neither metoprolol or propranolol changed tilt tolerance or cardiovascular variables, except for HR that remained at 57 +/- 2 (metoprolol) and 55 +/- 3 beats min-1 (propranolol), and MAP that remained at 87 +/- 5 mmHg during the first phase with metoprolol. In conclusion, sympathetic activation was crucial for the heart rate elevation during normotensive head-up tilt, but not for tilt tolerance or for the associated hypotension and bradycardia.
在8名男性中,使用美托洛尔(β1受体阻滞剂;0.29毫克/千克)和普萘洛尔(β1和β2受体阻滞剂;0.28毫克/千克)评估了交感β-肾上腺素能对50度头高位倾斜时心血管反应的影响。在23±3分钟后(对照组,平均值±标准误),一个血压正常-心动过速期之后是一个与晕厥前症状相关的低血压-心动过缓发作。头高位倾斜使胸段电阻抗(3.0±1.0欧姆)、平均动脉压(MAP,86±4-93±4毫米汞柱)、心率(HR,63±3-99±10次/分钟)和总外周阻力(TPR,15±1-28±4毫米汞柱·分钟/升)增加,而中心静脉血氧饱和度(74±2-58±4%)、心输出量(5.7±0.1-3.1±0.3升/分钟)、每搏输出量(95±6-41±5毫升)和脉压(55±4-49±4毫米汞柱)降低(P<0.05)。头高位倾斜期间中心静脉压降低(7±2-0±1毫米汞柱),但在持续倾斜期间保持稳定。在出现晕厥前症状时,MAP(49±3毫米汞柱)、HR(66±4次/分钟)和TPR(15±3毫米汞柱·分钟/升)降低(P<0.05)。除了心率在美托洛尔组保持在57±2次/分钟、普萘洛尔组保持在55±3次/分钟,以及在美托洛尔治疗的第一阶段MAP保持在87±5毫米汞柱外,美托洛尔或普萘洛尔均未改变倾斜耐受性或心血管变量。总之,交感神经激活对于血压正常的头高位倾斜期间心率升高至关重要,但对于倾斜耐受性以及相关的低血压和心动过缓并不重要。